MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Celator Pharmaceuticals Company Profile (NASDAQ:CPXX)

Consensus Ratings for Celator Pharmaceuticals (NASDAQ:CPXX) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.67 (6.48% upside)

Analysts' Ratings History for Celator Pharmaceuticals (NASDAQ:CPXX)
Show:
DateFirmActionRatingPrice TargetActions
5/19/2016Roth CapitalReiterated RatingBuy$22.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016Stifel NicolausInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Needham & Company LLCInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Janney Montgomery ScottInitiated CoverageBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016HC WainwrightBoost Price TargetBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015FBR & Co.Reiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2015MLV & Co.Reiterated RatingBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha